Selective cytotoxicity of azatyrosinamides against ras-transformed NIH 3T3 cells
Authors:
- H.P. WangHWH.P. Wang
- T.L. HwangTHT.L. Hwang
- On LeeOLOn Lee
- Y.J. TsengYTY.J. Tseng
- C.Y. ShuCSC.Y. Shu
- S.J. LeeSLS.J. Lee
- 1 October 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (19) , 4272-4274
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Post-translational incorporation of the antiproliferative agent azatyrosine into the C-terminus of α-tubulinBiochemical Journal, 2003
- Ras Family Signaling: Therapeutic TargetingCancer Biology & Therapy, 2002
- Ras-induced cellular eventsMolecular Membrane Biology, 2000
- Azatyrosine: Mechanism of Action for Conversion of Transformed Phenotype to NormalAnnals of the New York Academy of Sciences, 1999
- Reversion of human prostate tumorigenic growth by azatyrosineUrology, 1995
- The antibiotic azatyrosine suppresses progesterone or [Val12]p21 Ha-ras/insulin-like growth factor I-induced germinal vesicle breakdown and tyrosine phosphorylation of Xenopus mitogen-activated protein kinase in oocytes.Proceedings of the National Academy of Sciences, 1992
- Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine.Proceedings of the National Academy of Sciences, 1992
- Permanent conversion of mouse and human cells transformed by activatedras orraf genes to apparently normal cells by treatment with the antibiotic azatyrosineMolecular Carcinogenesis, 1989
- ras GENESAnnual Review of Biochemistry, 1987
- L-.BETA.-(5-Hydroxy-2-pyridyl)-alanine and L-.BETA.-(3-hydroxyureido)-alanine from streptomyces.Chemical and Pharmaceutical Bulletin, 1975